Heart-focused healthtech startup Tricog Health raised $8.5 million in Series B2 from investors including Omron Health Care and Sony Innovation Fund where existing investors The University of Tokyo Edge Capital, Inventus Partners, and SG Innovate also participated.

Tricog Health employs technology to analyse ECG and EKG scans and accurately diagnose anomalies. The startup also provides end users with portable ECG devices that can diagnose cardiovascular anomalies.

The TriCare platform from the healthtech startup offers an integrated solution for chronic disease management, allowing remote management of heart disease using medical data from connected devices at home and wearable devices such as the Apple Watch. The incoming funding will be used to expand the healthtech startup’s geographical presence in Asia and Africa.

Tricog Health aims to expand partnerships with government and private healthcare networks in order to make cardiac diagnosis and management more accessible and affordable.

Tricog claims to have installed its platform in over 5,000 catheterization labs, hospitals, clinics, and diagnostic centres to aid in the diagnosis and management of patients suffering from critical cardiac diseases such as heart attacks.

So far, the company claims to have screened 12 million patients and identified half a million serious heart patients. Tricog competes in a market dominated by incumbents such as Monitra Healthcare, Jeevtronics, Vieroots, and Sanket.

During the peak of the COVID-19 pandemic in 2020 and 2021, India’s healthtech sector experienced rapid growth. According to Inc42 data, between 2014 and Q1 2023, Indian healthtech startups raised more than $6 billion.

Heart-focused healthtech startup Tricog Health raised $8.5 million in Series B2 from investors including Omron Health Care and Sony Innovation Fund where existing investors The University of Tokyo Edge Capital, Inventus Partners, and SG Innovate also participated.

Tricog Health employs technology to analyse ECG and EKG scans and accurately diagnose anomalies. The startup also provides end users with portable ECG devices that can diagnose cardiovascular anomalies.

The TriCare platform from the healthtech startup offers an integrated solution for chronic disease management, allowing remote management of heart disease using medical data from connected devices at home and wearable devices such as the Apple Watch. The incoming funding will be used to expand the healthtech startup’s geographical presence in Asia and Africa.

Tricog Health aims to expand partnerships with government and private healthcare networks in order to make cardiac diagnosis and management more accessible and affordable.

Tricog claims to have installed its platform in over 5,000 catheterization labs, hospitals, clinics, and diagnostic centres to aid in the diagnosis and management of patients suffering from critical cardiac diseases such as heart attacks.

So far, the company claims to have screened 12 million patients and identified half a million serious heart patients. Tricog competes in a market dominated by incumbents such as Monitra Healthcare, Jeevtronics, Vieroots, and Sanket.

During the peak of the COVID-19 pandemic in 2020 and 2021, India’s healthtech sector experienced rapid growth. According to Inc42 data, between 2014 and Q1 2023, Indian healthtech startups raised more than $6 billion.